兰地洛尔

兰地洛尔（CAS 133242-30-5）的公开数据库记录，列此仅供独立核对。

公开数据库收录的理化数据

这个物质在各数据库里的编号

数据库记载的用途

• Landiolol is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter. It is not intended for chronic use.
• Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
• Established Pharmacologic Class [EPC] - beta-Adrenergic Blocker
• Mechanisms of Action [MoA] - Adrenergic beta1-Antagonists
• Landiolol is a beta-Adrenergic Blocker. The mechanism of action of landiolol is as an Adrenergic beta1-Antagonist.

它在各数据库里的别名

Landiolol; 133242-30-5; ONO-1101; Ono 1101; LDLL600; 62NWQ924LH; LDLL-600; AOP200704; AOP-200704; DTXSID10158026; landiololum; RefChem:152225; DTXCID2080517; C07AB14; CID 15034750; Rapiblyk

计算机算出的分子描述符

数据库摘要

Landiolol · CAS 133242-30-5 · C25H39N3O8. UNII 62NWQ924LH. 熔点: 122-125.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。